Oncoinvent A

Oncoinvent A EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Oncoinvent A (ONCIN.OL) as of Nov 7, 2026 is -0.12. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -0.35 — a change of -65.71% (higher).

EV/OCF

-0.12

YoY

-65.71%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Oncoinvent A is 2025 -0.12 . EV/OCF (Enterprise Value to Operating Cash Flow) of Oncoinvent A was 2024 -0.35 . It decreases by -65.71% higher compared to the previous year.

The Oncoinvent A EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
0.90 NOK
Jan 1, 2019
0.33 NOK
Jan 1, 2020
2.25 NOK
Jan 1, 2021
-0.64 NOK
Jan 1, 2022
-0.15 NOK
Jan 1, 2023
-0.26 NOK
Jan 1, 2024
-0.35 NOK
Jan 1, 2025
-0.12 NOK
The Oncoinvent A EV/OCF history
YEAREV/OCFYoY
-0.12-65.71%
-0.35+32.75%
-0.26+79.42%
-0.15-77.14%
-0.64-128.35%
2.25+588.07%
0.33-63.63%
0.90-14.99%
1.06-527.94%
-0.25-87.01%
-1.90—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oncoinvent A Stock analysis

What does Oncoinvent A do? Oncoinvent ASA is a radiopharmaceutical company based in Oslo, Norway, operating within the Health Care sector. Listed on 13 December 2024, the firm employs 46 people and focuses on developing alpha-emitting radiotherapeutics for cancer patients. Its primary product, Radspherin, is an alpha-emitting radioactive microsphere therapy designed to treat metastatic cancers in body cavities. This suspension of calcium carbonate microspheres labelled with Radium-224 targets residual micro-metastases on intracavitary surfaces and in liquids after surgery, aiming to spare deeper organs from harmful radiation doses. Oncoinvent A is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncoinvent A stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Oncoinvent A is -0.12 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Oncoinvent A changed from -0.35 to -0.12, representing a -65.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Oncoinvent A since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Oncoinvent A with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Oncoinvent A

All Key Metrics — Oncoinvent A